Roxadustat in CKD and transplant patients: A new era in anemia management (TTS 2026) - Sep 17, 2026 - Abstract #P3.647; Pres time: Sep 21, 2026; 04:45 PM - 06:00 PM; Location: Hall 1-2; P3; "Roxadustat appears to be an effective and generally safe therapeutic option for managing anemia in CKD patients, including those who are HDD, NDD, or RTRs. However, monitoring for cardiovascular events, such as myocardial infarction, is essential in these patients."
Clinical • Anemia • Cardiovascular • Chronic Kidney Disease • Hematological Disorders • Myocardial Infarction • Nephrology • Renal Disease • Transplantation
|
|
Muhammad Tassaduq Khan1; Rashid Bin Hamid1; Sidra Rashid1
|